SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates The Following Mergers; Shareholders Are Encouraged To Contact The Firm

NEW YORK, Aug. 18, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating: Jernigan Capital, Inc.
Author:
Publish date:

NEW YORK, Aug. 18, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating:

Jernigan Capital, Inc. (JCAP) - Get Report  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to an affiliate of NexPoint Advisors, L.P. Under the terms of the agreement, Jernigan Capital common stockholders will receive $17.30 per share in cash.  To learn more about your legal rights and options, visit:  https://halpersadeh.com/actions/jernigan-capital-inc-stock-merger-jcap-nexpoint/.

NTN Buzztime, Inc. (NTN) - Get Report  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Brooklyn ImmunoTherapeutics LLC. Under the terms of the merger, immediately following the closing, the members of Brooklyn will collectively own 94.08% of the outstanding common stock of the combined company and NTN Buzztime stockholders will collectively own 5.92% of the outstanding common stock of the combined company, which percentages are subject to adjustment. To learn more about your legal rights and options, visit:  https://halpersadeh.com/actions/ntn-buzztime-inc-stock-merger-brooklyn/.

Varian Medical Systems, Inc. (VAR) - Get Report  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siemens Healthineers AG for $177.50 per share.  To learn more about your legal rights and options, visit:  https://halpersadeh.com/actions/varian-medical-systems-inc-var-stock-merger-siemens.

Spring Bank Pharmaceuticals, Inc. (SBPH) - Get Report concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its proposed merger with F-star Therapeutics, Limited. Under the terms of the share exchange agreement, Spring Bank will acquire all of the outstanding share capital of F-star in exchange for the issuance of newly issued shares of Spring Bank common stock. Spring Bank shareholders will own approximately 38.8% of the combined company.  To learn more about your legal rights and options, visit:  https://halpersadeh.com/actions/spring-bank-pharmaceuticals-inc-sbph-stock-merger-fstar/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:Halper Sadeh LLP Daniel Sadeh, Esq. Zachary Halper, Esq.(212) 763-0060 sadeh@halpersadeh.com  zhalper@halpersadeh.com   https://www.halpersadeh.com

View original content to download multimedia: http://www.prnewswire.com/news-releases/shareholder-investigation-alert-halper-sadeh-llp-investigates-the-following-mergers-shareholders-are-encouraged-to-contact-the-firm-301114330.html

SOURCE Halper Sadeh LLP